Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,150 | 28,560 | N/A | 6,280 | 3,490 |
| Marketable Securities | 3,500 | 1,470 | N/A | 17,310 | 24,120 |
| Receivables | 270 | 50 | N/A | 70 | 80 |
| Other current assets | 280 | 460 | 160 | 250 | 640 |
| TOTAL | $42,200 | $30,540 | $160 | $23,910 | $28,330 |
| Non-Current Assets | |||||
| PPE Net | 220 | 180 | N/A | 180 | 150 |
| Investments And Advances | 0 | 600 | 0 | 0 | 0 |
| Other Non-Current Assets | 710 | 0 | 160 | 4,700 | 5,080 |
| TOTAL | $930 | $780 | $160 | $4,880 | $5,230 |
| Total Assets | $43,140 | $31,330 | $320 | $28,810 | $33,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,420 | 3,720 | 4,280 | 2,640 | 2,610 |
| TOTAL | $2,420 | $3,720 | $4,280 | $2,640 | $2,610 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | N/A | 0 | 150 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $150 |
| Total Liabilities | $2,420 | $3,720 | $4,280 | $2,640 | $2,760 |
| Shareholders' Equity | |||||
| Common Shares | 150,720 | 116,110 | 89,900 | 86,820 | 83,080 |
| Retained earnings | -134,730 | -104,560 | N/A | -75,360 | -65,030 |
| Other shareholders' equity | 5,890 | 3,970 | 3,230 | 5,000 | 4,220 |
| TOTAL | $40,710 | $27,610 | $105,730 | $26,170 | $30,790 |
| Total Liabilities And Equity | $43,130 | $31,330 | $110,010 | $28,810 | $33,550 |